Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 10 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2025 Filed Mar 18, 2025 20:53 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 6,354 | $3.66 | $23,255.64 |
DisclosureSEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,270,134 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:53 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 9,188 | $3.66 | $33,628.08 |
DisclosureSEC source: 0001801170-25-000073 · wk-form4_1742331202.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,276,488 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 20:51 UTC |
Wai ConradCEO, Counterpart Health
|
Tax withholdingClass A Common Stock | 80,524 | $3.66 | $294,717.84 |
DisclosureSEC source: 0001801170-25-000072 · wk-form4_1742331058.xml · nonDerivative · entry 1 Wai Conrad · CIK 0001971702 · CEO, Counterpart Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,263,539 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 20:12 UTC |
Edwards Carladenise ArmbristerDirector
|
SaleClass A Common Stock | 200,000 | $3.61 | $722,000.00 |
DisclosureSEC source: 0001801170-25-000068 · wk-form4_1741723964.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 273,227 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.54 to $3.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 23:11 UTC |
Priest Brady PatrickCEO of Home Care
|
SaleClass A Common Stock | 75,000 | $3.68 | $276,000.00 |
DisclosureSEC source: 0001801170-25-000066 · wk-form4_1741389106.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,418,151 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.68 to $3.70, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 06, 2025 Filed Mar 7, 2025 22:59 UTC |
Soares KarenGeneral Counsel & Secretary
|
SaleClass A Common Stock | 52,500 | $3.80 | $199,500.00 |
DisclosureSEC source: 0001801170-25-000064 · wk-form4_1741388350.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299,663 Read SEC document |
| February 14, 2025 Filed Feb 19, 2025 21:49 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 5,345 | $4.46 | $23,838.70 |
DisclosureSEC source: 0001801170-25-000043 · wk-form4_1740001752.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,352,163 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| February 08, 2025 Filed Feb 11, 2025 21:19 UTC |
Toy AndrewDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 85,535 | $4.32 | $369,511.20 |
DisclosureSEC source: 0001801170-25-000041 · wk-form4_1739308770.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,263,482 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:19 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 28,553 | $4.39 | $125,347.67 |
DisclosureSEC source: 0001801170-25-000039 · wk-form4_1738703965.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,357,508 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:18 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 21,578 | $4.39 | $94,727.42 |
DisclosureSEC source: 0001801170-25-000038 · wk-form4_1738703923.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,285,676 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:15 UTC |
Wai ConradCEO, Counterpart Health
|
Tax withholdingClass A Common Stock | 24,470 | $4.39 | $107,423.30 |
DisclosureSEC source: 0001801170-25-000036 · wk-form4_1738703750.xml · nonDerivative · entry 1 Wai Conrad · CIK 0001971702 · CEO, Counterpart Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,344,063 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:16 UTC |
Priest Brady PatrickCEO of Home Care
|
Tax withholdingClass A Common Stock | 18,987 | $4.39 | $83,352.93 |
DisclosureSEC source: 0001801170-25-000037 · wk-form4_1738703792.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,493,151 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 31, 2025, of 12.5% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in three equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 18, 2025 Filed Jan 22, 2025 22:04 UTC |
Priest Brady PatrickCEO of Home Care
|
Tax withholdingClass A Common Stock | 38,560 | $4.08 | $157,324.80 |
DisclosureSEC source: 0001801170-25-000031 · wk-form4_1737583467.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,512,138 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 18, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:34 UTC |
Garipalli VivekDirector · 10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 1,670,965 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 5 Garipalli Vivek · CIK 0001839260 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,904,343 Underlying: Class A Common Stock · 1,670,965 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F2 · derivative.exercise_price: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event. F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:34 UTC |
Garipalli VivekDirector · 10% owner
|
Exercise / conversionClass B Common Stock · Derivative | 3,342,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 4 Garipalli Vivek · CIK 0001839260 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,575,308 Underlying: Class A Common Stock · 3,342,698 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F2 · derivative.exercise_price: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event. F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:34 UTC |
Garipalli VivekDirector · 10% owner
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,342,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · derivative · entry 3 Garipalli Vivek · CIK 0001839260 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,342,699 Underlying: Class B Common Stock · 3,342,698 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021. F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021. F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021. F3 · derivative.underlying: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:34 UTC |
Garipalli VivekDirector · 10% owner
|
Tax withholdingClass A Common Stock | 1,670,965 | $3.60 | $6,015,474.00 |
DisclosureSEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · nonDerivative · entry 2 Garipalli Vivek · CIK 0001839260 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,409,267 F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F2 · shares: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:34 UTC |
Garipalli VivekDirector · 10% owner
|
Exercise / conversionClass A Common Stock | 1,670,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000027 · wk-form4_1736544833.xml · nonDerivative · entry 1 Garipalli Vivek · CIK 0001839260 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,080,232 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. F2 · shares: On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event. F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:11 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 4,308 | $3.60 | $15,508.80 |
DisclosureSEC source: 0001801170-25-000025 · wk-form4_1736543473.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,386,061 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on June 15, 2021. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:10 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 17,142 | $3.60 | $61,711.20 |
DisclosureSEC source: 0001801170-25-000024 · wk-form4_1736543420.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,307,254 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2025, due to the vesting of the final 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:41 UTC |
Tran Thomas LDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000017 · wk-form4_1736372458.xml · nonDerivative · entry 1 Tran Thomas L · CIK 0001403759 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,664 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:33 UTC |
SHAPIRO LEEDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000015 · wk-form4_1736371994.xml · nonDerivative · entry 1 SHAPIRO LEE · CIK 0001213350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 598,622 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:30 UTC |
Clinton ChelseaDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000013 · wk-form4_1736371799.xml · nonDerivative · entry 1 Clinton Chelsea · CIK 0001530920 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 602,814 F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs"). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 16:44 UTC |
Robinson William G JrDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000018 · wk-form4_1736372634.xml · nonDerivative · entry 1 Robinson William G Jr · CIK 0001604046 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 518,622 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:50 UTC |
Edwards Carladenise ArmbristerDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000019 · wk-form4_1736373009.xml · nonDerivative · entry 1 Edwards Carladenise Armbrister · CIK 0001937412 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473,227 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:39 UTC |
Loengard Anna UDirector
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000016 · wk-form4_1736372385.xml · nonDerivative · entry 1 Loengard Anna U · CIK 0001952723 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599,816 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. F2 · balance_after: The Reporting Person no longer has a reportable indirect beneficial interest in the following shares: (i) 20,000 shares of the Issuer's Class A Common Stock previously acquired by the Reporting Person and held by her now ex-spouse's IRA; and (ii) 1300 and 1500 shares of the Issuer's Class A Common Stock held by her Son's and Daughter's custodial accounts, respectively, and previously acquired by the Reporting Person. Each such holding was included in the Reporting Person's prior ownership report. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:28 UTC |
Kouzoukas Demetrios L.Director
|
GrantClass A Common Stock | 60,975 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-25-000012 · wk-form4_1736371725.xml · nonDerivative · entry 1 Kouzoukas Demetrios L. · CIK 0001856511 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 526,615 F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2025, subject to the Reporting Person's continued service as a director through such vesting date. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:12 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 8,149 | $3.29 | $26,810.21 |
DisclosureSEC source: 0001801170-25-000005 · wk-form4_1736284350.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,324,396 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2025, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:20 UTC |
Toy AndrewDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 278,765 | $3.15 | $878,109.75 |
DisclosureSEC source: 0001801170-25-000003 · wk-form4_1735939220.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,349,017 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2025, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 21:18 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 6,391 | $3.11 | $19,876.01 |
DisclosureSEC source: 0001801170-24-000251 · wk-form4_1734470327.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,390,369 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 15, 2024 Filed Dec 17, 2024 21:17 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 8,691 | $3.11 | $27,029.01 |
DisclosureSEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 2 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,332,545 F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 21:17 UTC |
Wai ConradCEO, Counterpart Health
|
Tax withholdingClass A Common Stock | 98,217 | $3.11 | $305,454.87 |
DisclosureSEC source: 0001801170-24-000249 · wk-form4_1734470256.xml · nonDerivative · entry 1 Wai Conrad · CIK 0001971702 · CEO, Counterpart Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,368,533 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 21:17 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 12,567 | $3.11 | $39,083.37 |
DisclosureSEC source: 0001801170-24-000248 · wk-form4_1734470222.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,341,236 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 14, 2024 Filed Nov 18, 2024 21:11 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 7,444 | $3.08 | $22,927.52 |
DisclosureSEC source: 0001801170-24-000238 · wk-form4_1731964288.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,396,760 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| November 08, 2024 Filed Nov 12, 2024 21:23 UTC |
Toy AndrewDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 85,367 | $3.41 | $291,101.47 |
DisclosureSEC source: 0001801170-24-000236 · wk-form4_1731446592.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627,782 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 23:37 UTC |
Soares KarenGeneral Counsel & Secretary
|
Tax withholdingClass A Common Stock | 152,040 | $4.12 | $626,404.80 |
DisclosureSEC source: 0001801170-24-000229 · wk-form4_1730763421.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,404,204 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:47 UTC |
Wai ConradCEO, Counterpart Health
|
Tax withholdingClass A Common Stock | 111,496 | $4.12 | $459,363.52 |
DisclosureSEC source: 0001801170-24-000228 · wk-form4_1730760424.xml · nonDerivative · entry 1 Wai Conrad · CIK 0001971702 · CEO, Counterpart Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,466,750 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:44 UTC |
Priest Brady PatrickCEO of Home Care
|
Tax withholdingClass A Common Stock | 100,320 | $4.12 | $413,318.40 |
DisclosureSEC source: 0001801170-24-000227 · wk-form4_1730760240.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,550,698 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 22:40 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 118,050 | $4.12 | $486,366.00 |
DisclosureSEC source: 0001801170-24-000225 · wk-form4_1730760036.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,353,803 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 31, 2024, of 50% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on October 31, 2023, and timely reported on a Form 4 filed on November 2, 2023. The remaining RSUs vest in four equal quarterly installments, with the final vesting date occurring on October 31, 2025, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 18, 2024 Filed Oct 22, 2024 20:07 UTC |
Priest Brady PatrickCEO of Home Care
|
Tax withholdingClass A Common Stock | 48,305 | $4.00 | $193,220.00 |
DisclosureSEC source: 0001801170-24-000217 · wk-form4_1729627629.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,651,018 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 18, 2024, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:17 UTC |
Soares KarenGeneral Counsel & Secretary
|
GrantClass A Common Stock | 450,955 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000215 · wk-form4_1729196226.xml · nonDerivative · entry 1 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,556,244 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:17 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
GrantClass A Common Stock | 726,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000214 · wk-form4_1729196216.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,471,853 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:16 UTC |
Priest Brady PatrickCEO of Home Care
|
GrantClass A Common Stock | 726,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000213 · wk-form4_1729196206.xml · nonDerivative · entry 1 Priest Brady Patrick · CIK 0001938197 · CEO of Home Care 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,699,323 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:16 UTC |
Wai ConradCEO, Counterpart Health
|
GrantClass A Common Stock | 726,114 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000212 · wk-form4_1729196197.xml · nonDerivative · entry 1 Wai Conrad · CIK 0001971702 · CEO, Counterpart Health 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,578,246 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 20:16 UTC |
Toy AndrewDirector · Chief Executive Officer
|
GrantClass A Common Stock | 1,910,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001801170-24-000211 · wk-form4_1729196186.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,713,149 F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of October 15, 2024, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of October 15, 2024, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on October 15, 2028. Read SEC document |
| October 03, 2024 Filed Oct 7, 2024 20:39 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 8,706 | $4.00 | $34,824.00 |
DisclosureSEC source: 0001801170-24-000200 · wk-form4_1728333576.xml · nonDerivative · entry 1 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,745,739 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 3, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:08 UTC |
Toy AndrewDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 308,341 | $2.78 | $857,187.98 |
DisclosureSEC source: 0001801170-24-000197 · wk-form4_1727903310.xml · nonDerivative · entry 1 Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,802,321 F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 1, 2024, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 20:07 UTC |
Soares KarenGeneral Counsel & Secretary
|
Disposition to issuerClass A Common Stock | 6,391 | $2.99 | $19,109.09 |
DisclosureSEC source: 0001801170-24-000191 · wk-form4_1726603636.xml · nonDerivative · entry 3 Soares Karen · CIK 0001999086 · General Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,105,289 F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 15, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 15, 2024 Filed Sep 17, 2024 20:06 UTC |
Reynoso Jamie L.CEO, Medicare Advantage
|
Tax withholdingClass A Common Stock | 8,691 | $2.99 | $25,986.09 |
DisclosureSEC source: 0001801170-24-000190 · wk-form4_1726603594.xml · nonDerivative · entry 4 Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,754,445 F4 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 15, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022, and originally reported on a Form 4 filed on September 20, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on September 16, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
| September 14, 2024 Filed Sep 17, 2024 20:07 UTC |
Wai ConradChief Technology Officer
|
Tax withholdingClass A Common Stock | 98,217 | $2.99 | $293,668.83 |
DisclosureSEC source: 0001801170-24-000192 · wk-form4_1726603663.xml · nonDerivative · entry 3 Wai Conrad · CIK 0001971702 · Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,852,132 F3 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on September 14, 2024, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on March 14, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.